Skip to main content
Top

Sodium–chloride difference is not strongly correlated with base excess in chronic kidney disease: an anion gap problem

Published in:

Abstract

Introduction

The prevalence of metabolic acidosis is high in patients with chronic kidney disease (CKD). For the diagnosis, a blood gas analysis is necessary, but not always available. The aim of the study was to evaluate the base excess (BE) of the sodium–chloride difference (BENa–Cl = Na+–Cl—34 mmol/l) as a screening parameter for hyperchloremic metabolic acidosis.

Methods and statistical analysis

We retrospectively performed acid–base analyses of 168 non-dialysed patients with CKD according to the physiologic and to the Stewart’s approach. We performed linear regression analysis, Bland–Altman plot and receiver operating characteristics (ROC) analysis of BENa–Cl and BE to evaluate the accuracy of BENa–Cl predicting the BE. We further investigated possible confounding factors.

Results

The corrected R2 for the correlation of BENa–Cl and BE was 0.60 (p < 0.001). The Bland–Altman plot showed a good overall agreement. The bias was negligible, but the 95%-limits of agreement showed a wide interval (10.4 mmol/l). For BE ≤ 2 mmol/l, the ROC analysis yielded an AUC of 0.89 and moderate sensitivity (0.75) and specificity (0.86) for the optimal BENa–Cl threshold (≤ 2 mmol/l). Subgroup analysis showed similar results. The main factor for the imprecision of BENa–Cl predicting the BE across all stages of CKD is the variability of the serum anion gap (SAG).

Conclusions

The BENa–Cl is not an adequate parameter for screening of hyperchloremic acidosis because of the high variability of the SAG. Only, if the BENa–Cl is ≤ 5 mmol/l, a hyperchloremic acidosis should be suspected. Therefore, a complete blood gas analysis is necessary for the correct diagnosis of acid–base disorders in patients with chronic kidney disease.
Title
Sodium–chloride difference is not strongly correlated with base excess in chronic kidney disease: an anion gap problem
Authors
Moritz Kerbl-Knapp
Gregor Lindner
Georg-Christian Funk
Christoph Schwarz
Publication date
11-11-2024
Publisher
Springer Netherlands
Published in
International Urology and Nephrology / Issue 3/2025
Print ISSN: 0301-1623
Electronic ISSN: 1573-2584
DOI
https://doi.org/10.1007/s11255-024-04274-4
This content is only visible if you are logged in and have the appropriate permissions.
This content is only visible if you are logged in and have the appropriate permissions.

Keynote webinar | Spotlight on progress in colorectal cancer

  • Live
  • Webinar | 11-12-2025 | 18:00 (CET)

CRC remains a major global health burden, but advances in screening, treatment, and lifestyle-based prevention continue to reshape clinical practice. Gain insights into how the latest research can be leveraged to optimize patient care across the CRC continuum.

Watch it live: Thursday 11 December 2025, 18:00-19:30 (CET)

Prof. Antoni Castells
Prof. Edward Giovannucci
Join the webinar
Webinar

2025 ESMO Congress hub

Unlock your free and exclusive access to expert interviews, news, and more from the annual congress of the European Society for Medical Oncology.

Read more

Keynote webinar | Spotlight on functional neurological disorder

FND perplexes and frustrates patients and physicians alike. Limited knowledge and insufficient awareness delays diagnosis and treatment, and many patients feel misunderstood and stigmatized. How can you recognize FND and what are the treatment options?

Prof. Mark Edwards
Watch now
Video
Image Credits
Colon cancer illustration/© (M) KATERYNA KON/SCIENCE PHOTO LIBRARY / Getty Images, Cancer cell screening and treatment concept/© artacet / iStock / Getty Images Plus, Human brain illustration/© (M) CHRISTOPH BURGSTEDT / SCIENCE PHOTO LIBRARY / Getty Images